ClinConnect ClinConnect Logo
Search / Trial NCT06693934

Jockey Club Precision Prevention Programme on Young Onset Diabetes

Launched by JULIANA CN CHAN · Nov 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Diabetes Pre Diabetes Yod Dm Young Onset Diabetes Genetic Test Management Prevention Hypertension Dyslipidemia Obesity

ClinConnect Summary

The Jockey Club Precision Prevention Programme is a community-based study aimed at detecting and preventing young onset diabetes in adults aged 18 to 44 who have at least one risk factor for diabetes, such as obesity, a family history of diabetes, or high blood pressure. Participants will provide a saliva sample for DNA testing and a small blood sample, and complete a questionnaire. Based on their results, they will be classified as either high or low risk for developing diabetes. Those identified as high risk will have regular check-ups and special support to help them manage their health better over two years.

If you qualify for this study, you'll receive personalized feedback about your health risks from healthcare professionals. You'll also have access to educational webinars to help you make healthier choices. The high-risk group will get additional tools and support, including consultations with healthcare providers, workshops, and even subsidies for medications or health devices to encourage positive lifestyle changes. This program not only aims to track how well participants do but also looks at how effective and accessible the program is for the community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged between 18 and 44 years old
  • With at least one risk factor for diabetes
  • Exclusion Criteria:
  • Known history of Diabetes
  • With conditions considered not suitable by the project team (including illiteracy)
  • The risk factors for diabetes include central or general obesity, family history of diabetes, smoking history, history of hypertension/ high blood glucose level/ abnormal lipid level/ vascular disease/ fatty liver, history of gestational diabetes/ polycystic ovary syndrome/ delivery of baby≥ 4kg (for women only), and less than 150mins of physical activity every week.

About Juliana Cn Chan

Juliana C.N. Chan is an esteemed clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a robust background in clinical pharmacology and an emphasis on innovative therapeutic solutions, Ms. Chan leads initiatives designed to rigorously evaluate new treatments across various therapeutic areas. Her collaborative approach fosters partnerships with research institutions, healthcare professionals, and regulatory bodies, ensuring adherence to the highest ethical standards and scientific integrity. Through her leadership, Juliana C.N. Chan is dedicated to translating research findings into actionable healthcare advancements that enhance the quality of life for patients worldwide.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Juliana CN Chan

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported